Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study
European Journal of Clinical Pharmacology · 2024
DOI: 10.1007/s00228-024-03689-3 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Clinical Pharmacology, 2024. Verfasst von Xinhai Huang und 17 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Dabigatran, Rivaroxaban, Atrial Fibrillation, Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Fujian Medical University, Fuzhou, China.
- Department of Pharmacy, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, #18 Daoshan Road, Fuzhou, 350001, China.
- Department of Pharmacy, Tongji Shanxi Hospital, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China.
- Department of Pharmacy, Suining Central Hospital, Suining, Sichuan, 629000, China.
- Department of Pharmacy, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of Pharmacy, People's Hospital of He'nan University of Chinese Medicine, People's Hospital of Zhengzhou), Zhengzhou, China.
Zitieren
APA
Huang, X., Xu, W., Wu, G., Li, R., Gu, P., Zheng, Q., Liu, X., Dai, H., Lin, X., Liu, Y., Du, X., Su, J., Zhang, W., Zhang, M., Zhu, Z., Huang, X., Huang, N., & Zhang, J. (2024). Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03689-3
Vancouver
Huang X, Xu W, Wu G, Li R, Gu P, Zheng Q, et al. Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study. European Journal of Clinical Pharmacology. 2024. doi:10.1007/s00228-024-03689-3
BibTeX
@article{Huang2024,
author = {Huang, Xinhai and Xu, Wenlin and Wu, Guilan and Li, Ruijuan and Gu, Ping and Zheng, Qiaowei and Liu, Xiumei and Dai, Hengfen and Lin, Xiangsheng and Liu, Yuxin and Du, Xiaoming and Su, Jun and Zhang, Wang and Zhang, Min and Zhu, Zhu and Huang, Xiaohong and Huang, Nianxu and Zhang, Jinhua},
title = {Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study},
journal = {European Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1007/s00228-024-03689-3}
}
EUVIMED